Efficacy and Safety Study of ALS-L1023 in Patients With Abdominal Obesity of Metabolic Syndrome

The main objective of this study is to evaluate efficacy and safety of ALS-L1023 tablet in patients with abdominal obesity of metabolic syndrome.

Lead sponsor: Hanmi Pharmaceutical Company Limited•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

COMPLETEDNA

Effect of Pyridoxamine Supplementation on Vascular Function and Insulin Sensitivity

NCT02954588 · Abdominal Obesity Metabolic Syndrome

COMPLETEDNA

Effects of Green-MED Diet Via the Gut-fat-brain Axis

NCT03020186 · Abdominal Obesity Metabolic Syndrome

TERMINATEDPhase 4

Aldosterone Antagonism and Microvascular Function

NCT01887119 · Abdominal Obesity Metabolic Syndrome, Insulin Resistance, and more

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: October 11, 2016Terms

Trial snapshot

StatusTERMINATED

PhasePHASE3

Enrollment200

Start dateMay 2013

Last updatedOct 11, 2016

Condition

Abdominal Obesity Metabolic Syndrome

Locations shown

5 Institutions

Seoul

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 11, 2016Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions